# GlaxoSmithKline LLC - Inspection Records

Source: https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928

> Inspection records and compliance data for GlaxoSmithKline LLC in Durham, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoSmithKline LLC
- FEI Number: 1035048
- City: Durham
- State: North Carolina
- Country Name: United States
- Address Line 1: 410 Blackwell St
- Zip Code: 27701

## Related Documents

- [FDA Inspection 1230726 - GlaxoSmithKline LLC - 2024-08-16](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/13c32f4d-414a-4526-845d-350d12295277) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2024
- [FDA Inspection 1103284 - GlaxoSmithKline LLC - 2019-09-12](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/fbf6b937-d3c2-4538-b1fb-8a2081d0f4d8) — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2019
- [EIR - GlaxoSmithKline LLC - 2016-07-15](https://www.keypedia.com/records/eir/glaxosmithkline-llc/be8f57d1-5818-4270-9aa4-bafffac721e9) — source: FDA, date: July 15, 2016
- [FDA Inspection 988235 - GlaxoSmithKline LLC - 2016-07-15](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/53d064fa-5f58-4b4c-93f0-cf5e2a0894d9) — classification: No Action Indicated (NAI), source: FDA, date: July 15, 2016
- [EIR - GlaxoSmithKline LLC - 2015-04-10](https://www.keypedia.com/records/eir/glaxosmithkline-llc/c0defc2a-5c08-451d-97ba-748c53905495) — source: FDA, date: April 10, 2015
- [FDA Inspection 921712 - GlaxoSmithKline LLC - 2015-04-10](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/599ec738-a209-474c-83fe-b9e3a029c589) — classification: No Action Indicated (NAI), source: FDA, date: April 10, 2015
- [FDA Inspection 898235 - GlaxoSmithKline LLC - 2014-09-29](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/eeb9cc30-e96a-4e77-89cb-4345bcc0d9fd) — classification: No Action Indicated (NAI), source: FDA, date: September 29, 2014
- [FDA Inspection 817398 - GlaxoSmithKline LLC - 2013-02-05](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/218356ac-c71c-4485-9ee1-d72dc2a20cc0) — classification: No Action Indicated (NAI), source: FDA, date: February 5, 2013
- [FDA Inspection 817128 - GlaxoSmithKline LLC - 2013-01-31](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/1f99b5ec-6307-409a-b09a-b88ee4f1e8a1) — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2013
- [FDA Inspection 810896 - GlaxoSmithKline LLC - 2012-12-19](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/c783485b-52e4-4495-b720-c22c9b8ba5a0) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2012
- [EIR - GlaxoSmithKline LLC - 2012-08-09](https://www.keypedia.com/records/eir/glaxosmithkline-llc/7552b94f-49df-400e-aa75-b62fdb80583f) — source: FDA, date: August 9, 2012
- [FDA Inspection 675227 - GlaxoSmithKline LLC - 2010-07-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/9222947e-1ef9-4606-b184-e7de71f372da) — classification: No Action Indicated (NAI), source: FDA, date: July 27, 2010
- [FDA Inspection 654076 - GlaxoSmithKline LLC - 2010-02-19](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/2330ac68-0af4-4936-bc1e-665929604bc2) — classification: No Action Indicated (NAI), source: FDA, date: February 19, 2010

## Related Companies

- [Nebraska Methodist Hospital](https://www.keypedia.com/companies/nebraska-methodist-hospital/3f3f8320-f8e3-45f8-a0fe-de35ca4a81f8)
- [Generitech Corporation](https://www.keypedia.com/companies/generitech-corporation/25805817-388a-4536-8a14-7e1b75078fba)
- [Ocho Rios-Miami, Inc.](https://www.keypedia.com/companies/ocho-rios-miami-inc/6ada2801-076f-444b-a36f-ee0d35ae8aa7)
- [Linemaster Switch Corporation](https://www.keypedia.com/companies/linemaster-switch-corporation/651f7d58-aaf7-4ee7-a5d5-320a27d1c4d7)
- [Neurolumen LLC](https://www.keypedia.com/companies/neurolumen-llc/2e53eb6e-6247-4069-ade9-cef49b1b8f04)
- [IVF/ART Laboratories/JHH at Green Spring Station](https://www.keypedia.com/companies/ivfart-laboratoriesjhh-at-green-spring-station/e304e0b8-1848-49f7-9a86-158b4627de3c)
- [Valentine Enterprises, Inc.](https://www.keypedia.com/companies/valentine-enterprises-inc/4a176a6d-efc8-4886-9b36-b274f5071695)
- [Lymol Medical Corporation](https://www.keypedia.com/companies/lymol-medical-corporation/a98bac62-27b5-4afb-897b-aed3e10e1d9c)
- [Stason Pharmaceuticals, Inc.](https://www.keypedia.com/companies/stason-pharmaceuticals-inc/f8669d38-d60b-4f0c-856a-ac536c422fae)
- [Huestis Machine Corporation](https://www.keypedia.com/companies/huestis-machine-corporation/744c0dee-8cae-4284-aee1-cf970bbbcdb7)

## Related Officers

- [company_representative](https://www.keypedia.com/people/nicole-taylor/32b3ee89-2da8-40ae-8445-039e844f7b1f)
- [issuing_officer](https://www.keypedia.com/people/nicole-m-bell/56a038c4-9323-43ac-93d7-0b6911286b73)
- [Betsy C. Galliher](https://www.keypedia.com/people/betsy-c-galliher/04add63c-cbcb-42f7-b634-7c2925600bef)
- [company_representative](https://www.keypedia.com/people/thomas-a-lampkin/bb7497cb-629a-42f4-9170-ab77fb023dac)
- [company_representative](https://www.keypedia.com/people/barbara-j-devans/26f4d01e-e0c0-4a8d-8493-f0a5581ad1ed)
- [Commissioned Corps of the U.S. Public Health Service](https://www.keypedia.com/people/adam-r-cooke/337c005d-e9dc-4512-aadb-ee0b0c637bd5)